Rapid Rx Quiz: Sexual Desire and Performance Medications

Mary L Windle, PharmD


April 11, 2022

Bremelanotide is indicated for treatment of premenopausal women with acquired, generalized HSDD, which is marked by reduced sexual desire that causes distress or interpersonal difficulty. Acquired HSDD develops in a patient who previously had no problems with sexual desire; generalized HSDD occurs regardless of the type of situation, stimulation, or partner. In contrast, situational HSDD occurs due to problems with the relationship, a coexisting medical or psychiatric condition, or effects of a medication or drug substance.

Learn more about bremelanotide.